Ultimately, managing methicillin-resistant infections in veterinary dermatology requires a shift from aggressive systemic intervention to strategic antimicrobial stewardship.

Oregon hospitals recorded nearly 1,000 infections that patients picked up while receiving care in 2024, resulting in ...

A research team at the University of Arizona College of Medicine–Tucson is developing a drug that works in combination with copper to kill bacteria, including those that cause MRSA, a type of staph ...

Ceftobiprole is a novel broad-spectrum cephalosporin antibiotic that has demonstrated significant efficacy in managing infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Its ...

The methicillin-resistant strain of Staphylococcus aureus (MRSA) kills a million people per year globally, making it one of the three deadliest bacteria in humans. This toll is expected to rise ...

MSSA and MRSA are Staphylococcus aureus (S. aureus) bacteria with different resistance patterns. MRSA is resistant to many antibiotics and is more difficult to treat. Both types of bacteria can cause ...

Antibiotics' contributions to modern medicine cannot be understated. They have significantly reduced disease-associated mortality and provided unprecedented extensions to human lifespans.

In the U.S., 296 hospitals have a methicillin-resistant Staphylococcus aureus infection rate of zero, as based on the healthcare-associated infections dataset from CMS. The Healthcare Associated ...

A recent study found permanent pacemaker infection (PPMI) in 2.09% patients, with infections more prevalent in devices ...